Iclusig
Active substance: ponatinib
TABLET, FILM COATED · PONATINIB HYDROCHLORIDE 45 mg/1
United StatesActive
Marketing holder: Takeda Pharmaceuticals America, Inc.
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
- PONATINIB HYDROCHLORIDE · 45 mg/1
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| EU 1 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-8b7b-787e-b70f-97baa91a39c5,01a1208e-a07b-7755-9e10-05e69f87c6a9,01a12098-f92f-7c3b-84cf-1d8a326340a0,01a1209b-7e03-7104-9d4b-1104ff640d10;count=4 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 63020-534
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 63020-534 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 63020-534 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 63020-534 · Verified 2026-10-09 · open in source